• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

更年期过渡期间症状的患病率和严重程度:澳大利亚女性中年期(AMY)研究的横断面研究结果

Prevalence and severity of symptoms across the menopause transition: cross-sectional findings from the Australian Women's Midlife Years (AMY) Study.

作者信息

Islam Rakibul M, Bond Molly, Ghalebeigi Aida, Wang Yuanyuan, Walker-Bone Karen, Davis Susan R

机构信息

School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

Roy Morgan, Melbourne, VIC, Australia.

出版信息

Lancet Diabetes Endocrinol. 2025 Sep;13(9):765-776. doi: 10.1016/S2213-8587(25)00138-X. Epub 2025 Jul 25.

DOI:10.1016/S2213-8587(25)00138-X
PMID:40720963
Abstract

BACKGROUND

The premenopause-to-perimenopause transition is defined by the Stages of Reproductive Aging Workshop +10 (STRAW+10) criteria according to changed menstrual cycle frequency. However, this approach is unhelpful for women and gender-diverse people with oligomenorrhoea or amenorrhoea, and also because a range of diverse symptoms have been ascribed to menopause. We investigated the prevalence and severity of symptoms from the late reproductive stage to late postmenopause, identifying those which might best differentiate menopause onset.

METHODS

The Australian Women's Midlife Years (AMY) Study was a nationally representative cross-sectional study of women aged 40-69 years who were recruited via a non-probability panel using online and offline sources between Oct 27, 2023, and March 19, 2024. To be eligible, participants needed to be able to complete a questionnaire in English. Menopausal symptoms were assessed using the Menopause-specific Quality of Life (MENQOL) questionnaire. Symptom prevalence and severity over the previous 4 weeks was calculated with 95% CIs, with prevalence ratios adjusted for age, BMI, and other demographic variables.

FINDINGS

8096 women were recruited: 5509 women were classified using STRAW+10 as premenopausal (n=1250), early perimenopausal (n=344), late perimenopausal (n=271), and postmenopausal (n=3644). Among moderately-to-severely bothersome symptoms, hot flushes showed the greatest change in prevalence from premenopause (8·8% [95% CI 7·2-10·4]) to late perimenopause (37·3% [31·5-43·0]; adjusted prevalence ratio 4·74 [95% CI 3·64-6·19]). Less variation was apparent for other symptoms, including poor memory and low mood. Vaginal dryness was the most discriminative sexual symptom from premenopause to late perimenopause (adjusted prevalence ratio 2·54 [95% CI 1·78-3·61]). Women with vasomotor symptoms and changed menstrual flow had more prevalent moderately-to-severely bothersome symptoms compared with women without vasomotor symptoms. Compared with premenopausal women with vasomotor symptoms and changed menstrual flow, early perimenopausal women with vasomotor symptoms reported a higher prevalence of poor memory (adjusted prevalence ratio 1·36 [95% CI 1·06-1·75]).

INTERPRETATION

Our findings suggest that moderately-to-severely bothersome vasomotor symptoms can reliably indicate the onset of perimenopause in women with oligomenorrhoea or amenorrhoea. Although other symptoms might be caused or exacerbated by menopause, other factors contributing to their occurrence need to be considered and included in management and care. Additionally, treatment options and care pathways are crucial to improve wellbeing during the perimenopause.

FUNDING

National Health and Medical Research Council.

TRANSLATIONS

For the Chinese and Spanish translations of the abstract see Supplementary Materials section.

摘要

背景

绝经前到围绝经期的转变是根据生殖衰老阶段研讨会+10(STRAW+10)标准,依据月经周期频率的变化来定义的。然而,这种方法对月经过少或闭经的女性及性别多样化人群并无帮助,而且因为一系列不同的症状都被归因于更年期。我们调查了从生殖后期到绝经后期症状的患病率和严重程度,确定那些最能区分更年期开始的症状。

方法

澳大利亚女性中年期(AMY)研究是一项具有全国代表性的横断面研究,研究对象为年龄在40 - 69岁的女性,于2023年10月27日至2024年3月19日通过非概率抽样小组,利用线上和线下渠道招募。要符合条件,参与者需能够用英语完成问卷。使用更年期特异性生活质量(MENQOL)问卷评估更年期症状。计算前4周症状的患病率和严重程度,并给出95%置信区间,患病率比根据年龄、体重指数和其他人口统计学变量进行调整。

研究结果

共招募了8096名女性:5509名女性根据STRAW+10被分类为绝经前(n = 1250)、围绝经期早期(n = 344)、围绝经期晚期(n = 271)和绝经后(n = 3644)。在中度至重度困扰症状中,潮热从绝经前(8.8% [95%置信区间7.2 - 10.4])到围绝经期晚期(37.3% [31.5 - 43.0];调整后的患病率比4.74 [95%置信区间3.64 - 6.19])的患病率变化最大。其他症状,包括记忆力差和情绪低落,变化不太明显。从绝经前到围绝经期晚期,阴道干燥是最具鉴别性的性症状(调整后的患病率比2.54 [95%置信区间1.78 - 3.61])。与没有血管舒缩症状的女性相比,有血管舒缩症状且月经流量改变的女性中度至重度困扰症状更为普遍。与有血管舒缩症状且月经流量改变的绝经前女性相比,有血管舒缩症状的围绝经期早期女性记忆力差的患病率更高(调整后的患病率比1.36 [95%置信区间1.06 - 1.75])。

解读

我们的研究结果表明,中度至重度困扰的血管舒缩症状能够可靠地表明月经过少或闭经女性围绝经期的开始。尽管其他症状可能由更年期引起或加重,但需要考虑导致其出现的其他因素,并将其纳入管理和护理中。此外,治疗选择和护理途径对于改善围绝经期的健康状况至关重要。

资金来源

国家卫生与医学研究委员会。

翻译

摘要的中文和西班牙文翻译见补充材料部分。

相似文献

1
Prevalence and severity of symptoms across the menopause transition: cross-sectional findings from the Australian Women's Midlife Years (AMY) Study.更年期过渡期间症状的患病率和严重程度:澳大利亚女性中年期(AMY)研究的横断面研究结果
Lancet Diabetes Endocrinol. 2025 Sep;13(9):765-776. doi: 10.1016/S2213-8587(25)00138-X. Epub 2025 Jul 25.
2
Long-term hormone therapy for perimenopausal and postmenopausal women.围绝经期和绝经后女性的长期激素治疗
Cochrane Database Syst Rev. 2017 Jan 17;1(1):CD004143. doi: 10.1002/14651858.CD004143.pub5.
3
Women's experience of menopause: a systematic review of qualitative evidence.女性更年期经历:定性证据的系统评价
JBI Database System Rev Implement Rep. 2015 Sep 16;13(8):250-337. doi: 10.11124/jbisrir-2015-1948.
4
Dehydroepiandrosterone for women in the peri- or postmenopausal phase.绝经前后阶段女性使用脱氢表雄酮。
Cochrane Database Syst Rev. 2015 Jan 22;1(1):CD011066. doi: 10.1002/14651858.CD011066.pub2.
5
NIH State-of-the-Science Conference Statement on management of menopause-related symptoms.美国国立卫生研究院关于更年期相关症状管理的科学现状会议声明。
NIH Consens State Sci Statements. 2005;22(1):1-38.
6
Hormone therapy for sexual function in perimenopausal and postmenopausal women.围绝经期和绝经后女性性功能的激素治疗
Cochrane Database Syst Rev. 2013 Jun 5(6):CD009672. doi: 10.1002/14651858.CD009672.pub2.
7
The mental health challenges, especially suicidality, experienced by women during perimenopause and menopause: A qualitative study.围绝经期和绝经期间女性所面临的心理健康挑战,尤其是自杀倾向:一项定性研究。
Womens Health (Lond). 2025 Jan-Dec;21:17455057251338941. doi: 10.1177/17455057251338941. Epub 2025 Jul 8.
8
Black cohosh (Cimicifuga spp.) for menopausal symptoms.黑升麻(升麻属植物)用于缓解更年期症状。
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD007244. doi: 10.1002/14651858.CD007244.pub2.
9
Long term hormone therapy for perimenopausal and postmenopausal women.围绝经期和绝经后女性的长期激素治疗。
Cochrane Database Syst Rev. 2012 Jul 11(7):CD004143. doi: 10.1002/14651858.CD004143.pub4.
10
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险